Clinical trial
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma…
NCT00417053 · Children's Cancer and Leukaemia Group, Other · Unknown status
Key facts
| NCT number | NCT00417053 |
|---|---|
| Title | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant |
| Official title | European Infant Neuroblastoma Study Final Protocol |
| Lead sponsor | Children's Cancer and Leukaemia Group, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, busulfan, carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide phosphate, melphalan, vincristine sulfate, autologous bone marrow transplantation, bone marrow ablation with stem cell support and 3 more |
| First posted | Dec 28, 2006 |
| Last update posted | Aug 2, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: